Home
Products
Gene
mRNA Products
mRNAs for Cancer Vaccine Research
mRNAs for Cancer Vaccine Research

mRNAs for Cancer Vaccine Research

Seattle Genova is one of the leading providers of life sciences products, offering a wide range of products, including mRNA services. Advancement in therapeutic medicine, mRNA has remarkably outcast everything to solve puzzles in the research field. With the increasing demand for mRNA and the help of Ph.D. experts, Seattle Genova has succeeded in developing services on mRNAs for cancer vaccine research. We provide high-quality cost-friendly products to meet our customer’s needs. Seattle Genova offers antibodies, bioactive proteins, virus particles, mRNA products, Stable cell lines, and research use kits in this category.  

Compare
Catalog Number
Gene Name
Product Name
More
AFP
AFP Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0031
AFP Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding AFP was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0031-LNP
AFP Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
AFP
AFP Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0032
AFP Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding AFP was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0032-LNP
AFP Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
GalT
GalT Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0033
GalT Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding GalT was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0033-LNP
GalT Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
AFP
AFP Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0034
AFP Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding AFP was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0034-LNP
AFP Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
p53
p53 Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0035
p53 Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding p53 was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0035-LNP
p53 Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
NY-ESO-1/B7-1/ICAM-1/LFA-3
NY-ESO-1/B7-1/ICAM-1/LFA-3 Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0036
NY-ESO-1/B7-1/ICAM-1/LFA-3 Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding NY-ESO-1/B7-1/ICAM-1/LFA-3 was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0036-LNP
NY-ESO-1/B7-1/ICAM-1/LFA-3 Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
CD80/CEA
CD80/CEA Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0037
CD80/CEA Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding CD80/CEA was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0037-LNP
CD80/CEA Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
CD80/CEA
CD80/CEA Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0038
CD80/CEA Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding CD80/CEA was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0038-LNP
CD80/CEA Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
CEA
CEA Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0039
CEA Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding CEA was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0039-LNP
CEA Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
CD80/CEA
CD80/CEA Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0040
CD80/CEA Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding CD80/CEA was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0040-LNP
CD80/CEA Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
Choose up to 4 products to compare
Compare
Clear All
0.251233s